Bio Essence (BIOE) Change in Accured Expenses (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Change in Accured Expenses of -$9113.0 in Q1 2026, down 126.6% quarter-over-quarter from $34265.0 in Q4 2025, and down 597.78% on a YoY basis from $1830.7 in Q1 2025.
Bio Essence (BIOE) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Bio Essence's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$9113.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 597.78% year-over-year to -$9113.0; the TTM figure through Mar 2026 stood at -$309844.0 (down 55.96% YoY), while the FY2025 annual figure was -$302037.0, down 419395.83% from the prior year.
- Change in Accured Expenses was -$9113.0 for Q1 2026 at Bio Essence, down from $34265.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $197295.0 in Q1 2024 to a low of -$334997.0 in Q3 2025.
- Historically, Change in Accured Expenses has averaged -$17889.4 across 5 years, with a median of -$2.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses sank 4040.7% in 2024, then soared 180442.11% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $4017.0 in 2022, then advanced by 17.8% to $4732.0 in 2023, then plunged by 100.4% to -$19.0 in 2024, then jumped by 180442.11% to $34265.0 in 2025, then slumped by 126.6% to -$9113.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$9113.0 (Q1 2026), $34265.0 (Q4 2025), and -$334997.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Bio Essence | - | - | 319,353.00 | -9,113.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,113.00 |
| Mar 31, 2026 | -9,113.00 |
| Dec 31, 2025 | 34,265.00 |
| Dec 31, 2025 | 34,265.00 |
| Sep 30, 2025 | -334,997.00 |
| Sep 30, 2025 | -334,997.00 |
| Jun 30, 2025 | 1.00 |
| Jun 30, 2025 | 1.00 |
| Mar 31, 2025 | -1,306.00 |
| Mar 31, 2025 | -1,306.00 |
| Dec 31, 2024 | -19.00 |
| Dec 31, 2024 | -19.00 |
| Sep 30, 2024 | -197,346.00 |
| Sep 30, 2024 | -197,346.00 |
| Jun 30, 2024 | -2.00 |
| Jun 30, 2024 | -2.00 |
| Mar 31, 2024 | 197,295.00 |
| Mar 31, 2024 | 197,295.00 |
| Dec 31, 2023 | 4,732.00 |
| Dec 31, 2023 | 4,732.00 |